AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

RecruitingNAAges 18 Years - anyAllNYU Langone Health
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 18 or older 2. No known anatomical abnormalities in either ear 3. English speaking 4. Intends to receive a cochlear implant in one ear (or has already received it but it has not been activated). 5. Normal hearing (or minimal hearing loss) in the contralateral ear Exclusion Criteria: 1. Under age 18 2. Documented anatomical abnormality of the implanted ear 3. Non-English speaking 4. Greater than minimal hearing loss in the contralateral ear.
๐Ÿ’Š

What it tests

  • Alternative Frequency Mapping
๐Ÿ“

Where

1 site
NYU Langone Health
New York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy